[연합뉴스 자료사진]
(Seoul = Yonhap News) Reporter Kim A-Ram = SK Bioscience is showing a 4% increase in the morning of the 19th, the second day of listing.
As of 10:20 am on the day, SK Biosciences is trading at 176,000 won, a 4.14% increase from the previous day.
As of this time, the intraday market capitalization is about 13.5 trillion won.
At the beginning of the market, it increased by more than 10%, but as profit-taking sales poured out, the rise was once reduced to the 1% level.
Currently, the trading volume is about 7.79 million shares. The transaction amount is about 1.45 trillion won, which is the first place in both KOSPI and KOSDAQ.
The previous day, the intraday contract volume reached 770,000 shares, but the remaining purchase amount reached 6.4 million shares.
Mirae Asset Daewoo[006800] In some securities company apps, such as, there was a connection failure due to a surge in orders at the beginning of the market.
SK Bioscience, in particular, has a large number of accounts that have been allocated stocks in the public offering, so it is easy to rush orders in large quantities at once.
Earlier, SK Bioscience entered the stock market as a’paid prize’ by jumping up to 169,000 won, which doubled the public offering the day before and added the upper limit.
Although the stock price has been strong for the second day, it has not yet achieved an upper limit for two days in a row after listing, which was highly anticipated by investors.
If it succeeds in’Bad Sangsang’, the stock price can rise to 219,000 won.
Unauthorized reproduction-redistribution prohibited>
2021/03/19 10:24 sent